> News > Perivision joins the Vanguard Accelerator
Perivision joins the Vanguard Accelerator
PeriVision is the latest company to be awarded a place on Biopôle’s six-month acceleration programme, the Vanguard Accelerator, which is dedicated to supercharging early-stage companies and projects.
PeriVision, which has been selected by the Vanguard experts for the full support package, combines AI algorithms, virtual reality and cloud computing to build the next-generation systems to test visual function. The first target market is visual field testing in glaucoma patient monitoring. PeriVision’s solution addresses the large unmet need for higher workflow efficiency in practices and hospitals and deeper clinical insight to better manage the eye disease.
PeriVision’s support from Vanguard will include expert coaching, regular meetings to help the company access the healthcare network and digital health stakeholders, as well as personalised follow-up from a Vanguard expert about specific business strategy topics. PeriVision moved into the Biopôle Digital Health Hub at the beginning of July 2022.
CEO and co-founder at PeriVision, Patrick Kessel, says: ‘We’re thrilled to connect with other healthcare innovators and the Vanguard mentors at Biopôle and leverage the outstanding ophthalmology expertise in the Lausanne region.’
Pierre-Jean Wipff, Director of Innovation and Partnerships at Biopôle and manager of the Vanguard Accelerator, says: ‘It’s an honour to support PeriVision in their next steps. By connecting the company with the regional ecosystem, the Vanguard Accelerator will help boost their innovation and take the business to the next level.’
PeriVision joins a community of Biopôle Vanguard start-ups, which includes digital health pioneers biped.ai, Gabi SmartCare, Impli, resilient, Sensemodi and XANA – all alumni of the accelerator. Anna Luisa Schaffgotsch, Founder and CEO of Impli, reflects on her experience: ‘We massively grew our network. It helped us to shape our business and position ourselves in a more mature way. Without Vanguard, we wouldn’t be where we are today!’
By connecting the company with the regional ecosystem, the Vanguard Accelerator will help boost their innovation and take the business to the next level.
Pierre-Jean Wipff, Director of Innovation and Partnerships at Biopôle and manager of the Vanguard Accelerator
Also, a second start-up – Carity AG – was shortlisted for Vanguard and has benefitted from Biopôle’s expert network. Carity has developed a digital coaching app and monitoring bracelet to support cardiac rehabilitation patients to regain confidence and motivation after a heart attack, helping them to stick to their rehabilitation programmes.
The Vanguard Accelerator is a free six-month programme, run by Biopôle SA and its partners, to help promising digital health-oriented projects supercharge their innovation and take their business strategy to the next level.
This immersive programme gives early-stage start-ups the opportunity to work with diverse and experienced digital health experts, who can advise on business plans and strategies. They include clinicians, nurses and pharmacists, alongside regulators, investors and IT specialists, all ready to offer their expertise. Start-ups selected for the accelerator programme benefit from exclusive real-world insights for business hypothesis testing and networking support to bring their innovation in digital health to life.